"Leading a relentless and enduring search for improved therapies of tomorrow."

During the past decade, Dermatology Research of Arkansas conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 3 clinical trials were completed. i.e. 30% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dermatology Research of Arkansas" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Dow Pharmaceutical Sciences" with 2 trials sponsored, "Galderma R&D" with 2 trials sponsored, "Stiefel, a GSK Company" with 2 trials sponsored and "Abbott" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dermatology Research of Arkansas" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Nektar Therapeutics" with 2 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Dermatology Research of Arkansas" are "Acne Vulgaris" (5 trials), "Atopic Dermatitis" (5 trials), "Psoriasis" (3 trials), "Dermatitis, Atopic" (2 trials) and "Eczema" (2 trials). Many other conditions were trialed in "Dermatology Research of Arkansas" in a lesser frequency.

Most popular intervention types in "Dermatology Research of Arkansas" are "Drug" (19 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Lebrikizumab" (4 trials), "Adapalene" (2 trials), "LY3471851" (2 trials) and "Vehicle" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dermatology Research of Arkansas" are 22 trials for "All" genders.

Currently, there are NaN active trials in "Dermatology Research of Arkansas". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Dermatology Research of Arkansas, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dermatology Research of Arkansas, 4 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".